Matthew Scott Harris - Net Worth and Insider Trading

Matthew Scott Harris Net Worth

The estimated net worth of Matthew Scott Harris is at least $296,468 dollars as of 2024-05-16. Matthew Scott Harris is the Chief Medical Officer of Altimmune Inc and owns about 33,311 shares of Altimmune Inc (ALT) stock worth over $296,468. Details can be seen in Matthew Scott Harris's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Matthew Scott Harris has not made any transactions after 2023-03-23 and currently still holds the listed stock(s).

Transaction Summary of Matthew Scott Harris

To

Matthew Scott Harris Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Matthew Scott Harris owns 1 companies in total, including Altimmune Inc (ALT) .

Click here to see the complete history of Matthew Scott Harris’s form 4 insider trades.

Insider Ownership Summary of Matthew Scott Harris

Ticker Comapny Transaction Date Type of Owner
ALT Altimmune Inc 2023-03-23 Chief Medical Officer

Matthew Scott Harris Latest Holdings Summary

Matthew Scott Harris currently owns a total of 1 stock. Matthew Scott Harris owns 33,311 shares of Altimmune Inc (ALT) as of March 23, 2023, with a value of $296,468.

Latest Holdings of Matthew Scott Harris

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
ALT Altimmune Inc 2023-03-23 33,311 8.90 296,468

Holding Weightings of Matthew Scott Harris


Matthew Scott Harris Form 4 Trading Tracker

According to the SEC Form 4 filings, Matthew Scott Harris has made a total of 2 transactions in Altimmune Inc (ALT) over the past 5 years, including 1 buys and 1 sells. The most-recent trade in Altimmune Inc is the acquisition of 10,000 shares on March 23, 2023, which cost Matthew Scott Harris around $42,200.

Insider Trading History of Matthew Scott Harris

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Matthew Scott Harris Trading Performance

GuruFocus tracks the stock performance after each of Matthew Scott Harris's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Matthew Scott Harris is -6.68%. GuruFocus also compares Matthew Scott Harris's trading performance to market benchmark return within the same time period. The performance of stocks bought by Matthew Scott Harris within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Matthew Scott Harris's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Matthew Scott Harris

Average Return

Average return per transaction

Outperforming Transactions

1 out of 1 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) 38.19
Relative Return to S&P 500(%) 33.51

Matthew Scott Harris Ownership Network

Ownership Network List of Matthew Scott Harris

No Data

Ownership Network Relation of Matthew Scott Harris


Matthew Scott Harris Owned Company Details

What does Altimmune Inc do?

Who are the key executives at Altimmune Inc?

Matthew Scott Harris is the Chief Medical Officer of Altimmune Inc. Other key executives at Altimmune Inc include Chief Financial Officer Richard I Eisenstadt , Chief Business Officer Raymond M Jordt , and director & President and CEO Vipin K Garg .

Altimmune Inc (ALT) Insider Trades Summary

Over the past 18 months, Matthew Scott Harris made 1 insider transaction in Altimmune Inc (ALT) with a net purchase of 10,000. Other recent insider transactions involving Altimmune Inc (ALT) include a net purchase of 9,300 shares made by David Drutz , a net sale of 20,000 shares made by Wayne Pisano , and a net purchase of 10,000 shares made by Richard I Eisenstadt .

In summary, during the past 3 months, insiders sold 0 shares of Altimmune Inc (ALT) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 20,000 shares of Altimmune Inc (ALT) were sold and 29,300 shares were bought by its insiders, resulting in a net purchase of 9,300 shares.

Altimmune Inc (ALT)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Altimmune Inc Insider Transactions

No Available Data

Matthew Scott Harris Mailing Address

Above is the net worth, insider trading, and ownership report for Matthew Scott Harris. You might contact Matthew Scott Harris via mailing address: C/o Altimmune, Inc., 910 Clopper Road, Suite 201s, Gaithersburg Md 20878.

Discussions on Matthew Scott Harris

No discussions yet.